Avant Technologies Evaluating Advanced Cells for Diabetes Therapy at 15th Annual EPITA Symposium

Stock Information for Avai Bio Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Avai Bio Inc.

Cell Therapies Moving From Lab to Factory Floor, and the Stocks Behind Them
Avaí Bio and Austrianova Begin Production of Master Cell Bank for Klotho Anti-Aging Therapy Under GMP Standards
5 Stocks Sitting on the Right Side of the Biggest Repricing in a Generation
Avant Technologies Completes Rebranding with Name Change to Avaí Bio and Launch of New Website
Longevity Biotech Stocks Surge as $27 Trillion Healthcare Shift Favors Cell Restoration
Breaking Barriers: How 2026's Top Clinical Leaders Are Disrupting Chronic Disease Markets
THE RESILIENCE DOCTRINE: 5 Assets Securing the 2026 Sovereign Stack
Breaking Barriers: How 2026's Top Clinical Leaders Are Disrupting Chronic Disease Markets

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.